{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T12:08:55Z","timestamp":1764936535655},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7,1]]},"DOI":"10.2146\/ajhp090394","type":"journal-article","created":{"date-parts":[[2010,6,16]],"date-time":"2010-06-16T16:33:43Z","timestamp":1276706023000},"page":"1075-1079","source":"Crossref","is-referenced-by-count":9,"title":["Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II"],"prefix":"10.1093","volume":"67","author":[{"given":"Jennifer J.","family":"Wellborn-Kim","sequence":"first","affiliation":[{"name":"Pharmacy Practice Department, College of Pharmacy, Nova Southeastern University\u2014West Palm Beach Campus, West Palm Beach, FL; at the time this research was conducted she was Postgraduate Year 1 Pharmacy Practice Resident, Pharmacy Department, Indian River Medical Center (IRMC), Vero Beach, FL."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George A.","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Cardiovascular Critical Care, The Heart Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"William F.","family":"Terneus","sequence":"additional","affiliation":[{"name":"Pharmacy Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cary L.","family":"Stowe","sequence":"additional","affiliation":[{"name":"Pharmacy Practice Department, College of Pharmacy, Nova Southeastern University\u2014West Palm Beach Campus, West Palm Beach, FL; at the time this research was conducted she was Postgraduate Year 1 Pharmacy Practice Resident, Pharmacy Department, Indian River Medical Center (IRMC), Vero Beach, FL."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Malias","sequence":"additional","affiliation":[{"name":"The Heart Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary M.","family":"Sparkman","sequence":"additional","affiliation":[{"name":"The Heart Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greer W.","family":"Hanson","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Division of Cardiovascular Critical Care, The Heart Center, IRMC"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041104242887800_b1-0671075","volume-title":"Arixtra (fondaparinux sodium for injection) package insert","year":"2005"},{"issue":"(suppl 2)","key":"key\n\t\t\t\t2019041104242887800_b2-0671075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-200241002-00001","article-title":"The pharmacokinetics of fondaparinux sodium in healthy volunteers","volume":"41","author":"Donat","year":"2002","journal-title":"Clin Pharmacokinet"},{"issue":"(suppl 1)","key":"key\n\t\t\t\t2019041104242887800_b3-0671075","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.3949\/ccjm.72.Suppl_1.S37","article-title":"Anticoagulation in special patient populations: are special dosing considerations required?","volume":"72","author":"Michota","year":"2005","journal-title":"Cleve Clin J Med"},{"key":"key\n\t\t\t\t2019041104242887800_b4-0671075","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1378\/chest.07-1826","article-title":"Differences between low-molecular-weight and unfractionated heparin for venous thromboembolism prevention following ischemic stroke: a metaanalysis","volume":"133","author":"Shorr","year":"2008","journal-title":"Chest"},{"issue":"(suppl)","key":"key\n\t\t\t\t2019041104242887800_b5-0671075","doi-asserted-by":"crossref","first-page":"340S","DOI":"10.1378\/chest.08-0677","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Warkentin","year":"2008","journal-title":"Chest"},{"issue":"(suppl)","key":"key\n\t\t\t\t2019041104242887800_b6-0671075","doi-asserted-by":"crossref","first-page":"381S","DOI":"10.1378\/chest.08-0656","article-title":"Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Geerts","year":"2008","journal-title":"Chest"},{"key":"key\n\t\t\t\t2019041104242887800_b7-0671075","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/MBC.0b013e328323da86","article-title":"Pharmacokinetic and clinical data supporting the use of fondaparinux 1.5 mg once daily in the prevention of venous thromboembolism in renally-impaired patients","volume":"20","author":"Turpie","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"key":"key\n\t\t\t\t2019041104242887800_b8-0671075","first-page":"ECR32","article-title":"Fondaparinux (ARIXTRA) as an alternative antithrombotic prophylaxis when there is hypersensitivity to low molecular weight and unfractionated heparins","volume":"88","author":"Parody","year":"2003","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t2019041104242887800_b9-0671075","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/ndt\/gfh544","article-title":"Use of fondaparinux (ARIXTRA) in a dialysis patient with symptomatic heparin-induced thrombocytopaenia type II","volume":"20","author":"Haase","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t2019041104242887800_b10-0671075","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/MPH.0b013e3181256ba5","article-title":"Treatment of thrombosis with fondaparinux (Arixtra) in a patient with end-stage renal disease receiving hemodialysis therapy","volume":"29","author":"Sharathkumar","year":"2007","journal-title":"J Pediatr Hematol Oncol"},{"key":"key\n\t\t\t\t2019041104242887800_b11-0671075","doi-asserted-by":"crossref","first-page":"198","DOI":"10.5414\/CPP46198","article-title":"Use of fondaparinux as an anticoagulant during hemodialysis: a preliminary study","volume":"46","author":"Sombolos","year":"2008","journal-title":"Int J Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t2019041104242887800_b12-0671075","volume-title":"Medical information letter. Use of Arixtra in patients with renal impairment","author":"GlaxoSmithKline","year":"2006"},{"key":"key\n\t\t\t\t2019041104242887800_b13-0671075","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1160\/TH07-07-0444","article-title":"Use of the pentasaccharide fondaparinux as an anticoagulant during haemodialysis","volume":"98","author":"Kalicki","year":"2007","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t2019041104242887800_b14-0671075","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood-2004-05-2010","article-title":"Effect of fondaparinux on platelet activation in the presence of heparin- dependent antibodies: a blinded comparative multicenter study with unfractionated heparin","volume":"105","author":"Savi","year":"2005","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019041104242887800_b15-0671075","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1345\/aph.1G738","article-title":"Fondaparinux for thromboembolic treatment and prophylaxis of heparin-induced thrombocytopenia","volume":"40","author":"Efird","year":"2006","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t2019041104242887800_b16-0671075","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1345\/aph.1M136","article-title":"Fondaparinux and the management of heparin-induced thrombocytopenia: the journey continues","volume":"43","author":"Blackmer","year":"2009","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t2019041104242887800_b17-0671075","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1055\/s-2004-831049","article-title":"A critical evaluation of assays for detecting antibodies to the heparin-PF4 complex","volume":"30","author":"Francis","year":"2004","journal-title":"Semin Thromb Hemost"},{"key":"key\n\t\t\t\t2019041104242887800_b18-0671075","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1538-7836.2006.01787.x","article-title":"Evaluation of pretest clinical score (4 T\u2019s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings","volume":"4","author":"Lo","year":"2006","journal-title":"J Thromb Haemost"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/67\/13\/1075\/28344320\/ajhp1075.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T00:57:19Z","timestamp":1559177839000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/67\/13\/1075\/5130796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,1]]},"references-count":18,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2010,7,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp090394","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,7,1]]},"published":{"date-parts":[[2010,7,1]]}}}